Mechanism of apoptosis induced by a new topoisomerase inhibitor through the generation of hydrogen peroxide

Abstract

TAS-103, a new anticancer drug, induces DNA cleavage by inhibiting the activities of topoisomerases I and II. We investigated the mechanism of TAS-103-induced apoptosis in human cell lines. Pulsed field gel electrophoresis revealed that in the leukemia cell line HL-60 and the H 2O 2-resistant subclone, HP100, TAS-103 induced DNA cleavage to form 1-2-Mb fragments at 1 h to a similar extent, indicating that the DNA cleavage was induced independently of H 2O 2. TAS-103-induced DNA ladder formation in HP100 cells was delayed compared with that seen at 4 h in HL-60 cells, suggesting the involvement of H 2O 2-mediated pathways in apoptosis. Flow cytometry revealed that H 2O 2 formation preceded increases in mitochondrial membrane potential (ΔΨm) and caspase-3 activation. Inhibitors of poly(ADP-ribose) polymerase (PARP) prevented both TAS-103-induced H 2O 2 generation and DNA ladder formation. The levels of NAD +, a PARP substrate, were significantly decreased in HL-60 cells after a 3-h incubation with TAS103. The decreases in NAD + levels preceded both increases in ΔΨm and DNA ladder formation. Inhibitors of NAD(P)H oxidase prevented TAS-103-induced apoptosis, suggesting that NAD(P)H oxidase is the primary enzyme mediating H 2O 2 formation. Expression of the antiapoptotic protein, Bcl-2, in BJAB cells drastically inhibited TAS-103-induced apoptosis, confirming that H 2O 2 generation occurs upstream of mitochondrial permeability transition. Therefore, these findings indicate that DNA cleavage by TAS-103 induces PARP hyperactivation and subsequent NAD + depletion, followed by the activation of NAD(P)H oxidase. This enzyme mediates O 2--derived H 2O 2 generation, followed by the increase in Δψm and subsequent caspase-3 activation, leading to apoptosis.